KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to -$4.4 million.

  • Opko Health's Change in Receivables fell 124220.18% to -$4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.6 million, marking a year-over-year increase of 2653.14%. This contributed to the annual value of $220000.0 for FY2024, which is 10644.97% up from last year.
  • Opko Health's Change in Receivables amounted to -$4.4 million in Q3 2025, which was down 124220.18% from $3.8 million recorded in Q2 2025.
  • Opko Health's Change in Receivables' 5-year high stood at $89.2 million during Q2 2023, with a 5-year trough of -$90.6 million in Q3 2023.
  • In the last 5 years, Opko Health's Change in Receivables had a median value of -$5.8 million in 2024 and averaged -$8.4 million.
  • Its Change in Receivables has fluctuated over the past 5 years, first soared by 451834.86% in 2021, then crashed by 124220.18% in 2025.
  • Quarter analysis of 5 years shows Opko Health's Change in Receivables stood at $22.7 million in 2021, then tumbled by 93.61% to $1.4 million in 2022, then skyrocketed by 267.59% to $5.3 million in 2023, then surged by 198.31% to $15.9 million in 2024, then tumbled by 127.6% to -$4.4 million in 2025.
  • Its Change in Receivables was -$4.4 million in Q3 2025, compared to $3.8 million in Q2 2025 and -$22.9 million in Q1 2025.